Skip to search boxSkip to navigationSkip to main content

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

  • Jerzy Jaroszewicz
    ,
  • ,
  • Karsten Wursthorn
    ,
  • Katja Deterding
    ,
  • Jerome Schlue
    ,
  • Regina Raupach
*Corresponding author for this work
  • Medical University of Białystok
    ,
  • Hannover Medical School
    ,
  • Robert Koch-Institut
    ,
  • University of Tübingen
Research Output:
Contribution to journal
Article
Research
Peer-review

Abstract

Background & Aims: The quantifiable level of HBsAg has been suggested as a predictor of treatment response in chronic hepatitis B. However, there is limited information on HBsAg levels considering the dynamic natural course of HBV-infection. This study aimed to determine HBsAg levels in the different phases of HBV-infection in European HBsAg-positive patients. Methods: 226 HBV-monoinfected patients, not undergoing antiviral therapy, were analyzed in a cross-sectional study. Patients were categorized according to the phase of HBV-infection: HBeAg(+) immune tolerance phase (IT, n = 30), immune clearance phase (IC, n = 48), HBeAg(-) low-replicative phase (LR, n = 68), HBeAg(-) hepatitis (ENH, n = 68), and acute hepatitis B (n = 12). HBsAg was quantified and correlated with HBV-DNA, HBV-genotypes and clinical parameters. In addition, 30 LR-patients were followed longitudinally. Results: HBsAg levels were higher in IT-patients and IC-patients compared to LR-patients and ENH-patients (4.96/4.37/3.09/3.87-log10 IU/ml, p < 0.001). HBsAg showed a strong correlation with HBV-DNA during acute hepatitis B (R = 0.79, p < 0.01). Correlation of HBsAg and HBV-DNA was weak or missing when analyzing different phases of persistent HBV-infection separately. However, associations between HBsAg and HBV-DNA were observed in patients infected with HBV-genotype D but not with HBV-genotype A. LR-patients with HBV-reactivation during follow-up (increase of HBV-DNA >2000 IU/ml) showed >3-fold higher baseline HBsAg levels with a NPV of 95% for an HBsAg cut-off of 3500 IU/ml. Conclusions: HBsAg levels show significant differences during the natural course of HBV-infection and between HBV-genotypes. These findings may have important implications for understanding the natural history of HBV-infection and for using quantitative HBsAg as a diagnostic tool, i.e. as a marker for predicting HBV-reactivation.

Research Output Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 514-522 (9 pages)

Journal (Volume, Issue Number)

Journal of Hepatology (Volume 52, Issue 4)

Publication milestones

  • Published - 04/2010

Publication status

Published - 04/2010

ISSN

0168-8278

Publication IDs

  • Scopus: 77949656255
  • PubMed: 20207438

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication metrics

Metrics

SciVal
citations
380
SciVal
FWCI
7.78
SciVal
Author count
11
SciVal
Paper percentile
98
SciVal
Top percentile
5
Scopus
citations

PlumX, opens in new tab

Mentions
3
Citation count
388
Captures
211